Annovis Bio Corporation (ANVS) - Forvard P/S multiplikatori

Annovis Bio Corporation (ANVS) - korporativ logo

Annovis Bio, Inc. (ANVS) patent himoyasidagi neyrodegeneratsiya terapiyasi sektorida raqobatlashmoqda, bu yerda asosiy xavf-xatarlar faqat hamkasblarning klinik tadqiqotlarining so'nggi bosqichlaridagi yutuqlari bilan cheklangan. Forward P/S koeffitsiyenti aktivning past baholanishi qiymat tuzog'i ekanligini aniqlashga yordam beradi va ushbu metrikaning eng so'nggi qiymatini aks ettiradi. Kompaniya daromadlari tadqiqot grantlariga tayanadi va hozirda kompaniya neyronlarni toksik proteinlardan tozalash uchun dori vositalarini faol ravishda ishlab chiqmoqda.

Annovis Bio - ANVS Kapitalizatsiyaning kutilayotgan sotuvga nisbati (davr: 04.07.2022 - 16.11.2026)

Annovis Bio, Inc. (ANVS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

Kompaniyaning har tomonlama tahlili:ANVS (Annovis Bio, Inc.)
Annovis Bio Corporation tomonidan chiqariladigan mahsulotlar

Biotehnologiya firmasi Annovis Bio, Inc. (ANVS) uchun, qayerda qat'iy sinov xarajatlari kontraktli sintez orqali marjaning keskin kengayishi potentsiali bilan birga mavjud, baholash kelajakdagi pul oqimlariga kritik darajada bog'liq bo'ladi. Kompaniyaning kutilayotgan P/S koeffitsiyenti joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan solishtiradi, bu esa investorlarga o'rtacha qiymatlarga nisbatan varians tahlili orqali kelajakdagi patent muvaffaqiyati uchun to'langan premium miqdorini aniqlash imkonini beradi.

Annovis Bio, Inc. raqobatchilari tahlili

Forvard P/S multiplikatori BIIB (Biogen Idec)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Neurocrine Corp (NBIX)|RGC: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx AXSM (Axsome Therapeutics)|ACAD: Forvard P/S multiplikatori|Xenon Pharmaceuticals Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Viking Pharma|SUPN: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori CPRX|Forvard P/S multiplikatori denalitherapeutics.com (DNLI)|Forvard P/S multiplikatori HRMY (Harmony Biosciences Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Biohaven (BHVN)|Amylyx Corp - Forvard P/S multiplikatori|TRVI - Forvard P/S multiplikatori|Praxis Precision Medicines Inc (PRAX) - Narxning prognoz qilingan daromadga nisbati|AVXL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati CeriBell|Forvard P/S multiplikatori Prothena Corporation plc|Narxning prognoz qilingan daromadga nisbati Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati omeros.com OMER|neurogene.com (NGNE) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|acimmune.com - Forvard P/S multiplikatori|Voyager Therapeutics Inc (VYGR) - Forvard narx/daromad multiplikatori|Neumora Corp (NMRA) - Narxning prognoz qilingan daromadga nisbati|Scilex Holding Company, Inc. (SCLX) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori TVGN|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alpha Cognition Inc. ACOG|Narxning prognoz qilingan daromadga nisbati cogrx.com (CGTX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Inhibikase Therapeutics, Inc.|Forvard P/S multiplikatori SAVA (Cassava Sciences Inc)|Forvard P/S multiplikatori Assertio Holdings, Inc. ASRT|COYA - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati Vistagen (VTGN)|OVID: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Acumen Pharmaceuticals Inc. (ABOS)|Forvard narx/daromad multiplikatori CRVO|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ATHE (Alterity Therapeutics)|Narxning prognoz qilingan daromadga nisbati Clene Nanomedicine (CLNN)|PEPG (PepGen) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Jupiter Neurosciences Inc JUNS|Sotuvga nisbatan forvard narx RLMD|Grace Tx - Forvard P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|KLTO: Forvard P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals, Inc.|Forvard narx/daromad multiplikatori metaviatx.com (MTVA)|Forvard P/S multiplikatori NRXS|HSDT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Passage Bio, Inc. - Forvard narx/daromad multiplikatori|bionomics.com.au (NEUP) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Minerva - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ATHA (Athira Pharma Inc)|ADXN: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Forvard P/S multiplikatori|PTIX (Protagenic Therapeutics) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori KTTA|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Cortigent|Forvard P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning prognoz qilingan daromadga nisbati|Cara Therapeutics Inc. - Forvard P/S multiplikatori|Chromocell Therapeutics (CHRO) - Forvard narx/daromad multiplikatori|ELYM: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Forvard P/S multiplikatori|Marinus - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori NKGN|NRBO (NeuroBo Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SAGE (Sage Therapeutics Inc)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synaptogenix Inc. (SNPX)|TRVN - Narxning prognoz qilingan daromadga nisbati|vigilneuro.com (VIGL) - Forvard narx/daromad multiplikatori|WENA: Forvard P/S multiplikatori|Cerevel Therapeutics, Inc. (CERE) - Forvard P/S multiplikatori